Erratum to: Development of a robust and sensitive pyrosequencing assay for the detection of IDH1/2 mutations in gliomas

Affiliations

¹ Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan.
² Division of Brain Tumor Translational Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 1040045, Japan.
³ Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
⁴ Department of Neurosurgery, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 1130033, Japan.
⁵ Division of Brain Tumor Translational Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 1040045, Japan. kichimur@ncc.go.jp.

Published Erratum

Hideyuki Arita et al. Brain Tumor Pathol. 2018 Jan.

. 2018 Jan;35(1):46-47.

doi: 10.1007/s10014-017-0277-9.

¹ Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan.
² Division of Brain Tumor Translational Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 1040045, Japan.
³ Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
⁴ Department of Neurosurgery, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 1130033, Japan.
⁵ Division of Brain Tumor Translational Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 1040045, Japan. kichimur@ncc.go.jp.

No abstract available

Erratum for

Development of a robust and sensitive pyrosequencing assay for the detection of IDH1/2 mutations in gliomas.
Arita H, Narita Y, Matsushita Y, Fukushima S, Yoshida A, Takami H, Miyakita Y, Ohno M, Shibui S, Ichimura K. Arita H, et al. Brain Tumor Pathol. 2015 Jan;32(1):22-30. doi: 10.1007/s10014-014-0186-0. Epub 2014 Apr 19. Brain Tumor Pathol. 2015. PMID: 24748374